Reviewing SIGA Technologies Inc. (SIGA)’s and Arvinas Inc. (NASDAQ:ARVN)’s results

We will be contrasting the differences between SIGA Technologies Inc. (NASDAQ:SIGA) and Arvinas Inc. (NASDAQ:ARVN) as far as institutional ownership, profitability, risk, dividends, analyst recommendations, earnings and valuation are concerned. The two businesses are rivals in the Biotechnology industry.

Valuation & Earnings

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
SIGA Technologies Inc. 5 0.00 49.67M 5.29 1.06
Arvinas Inc. 26 0.00 19.58M -5.73 0.00

Table 1 shows gross revenue, earnings per share (EPS) and valuation of the two companies.


Table 2 hightlights the return on equity, return on assets and net margins of the two companies.

Net Margins Return on Equity Return on Assets
SIGA Technologies Inc. 939,403,109.28% 0% 255.2%
Arvinas Inc. 75,656,877.90% 413.1% -120.9%


SIGA Technologies Inc.’s Current Ratio is 10.2 while its Quick Ratio is 10. On the competitive side is, Arvinas Inc. which has a 8.7 Current Ratio and a 8.7 Quick Ratio. SIGA Technologies Inc. is better positioned to pay off short and long-term obligations compared to Arvinas Inc.

Analyst Recommendations

SIGA Technologies Inc. and Arvinas Inc. Ratings and Recommendations are available in the next table.

Sell Ratings Hold Ratings Buy Ratings Rating Score
SIGA Technologies Inc. 0 0 0 0.00
Arvinas Inc. 0 0 6 3.00

Meanwhile, Arvinas Inc.’s average target price is $36.43, while its potential downside is -6.23%.

Institutional and Insider Ownership

Institutional investors held 30.7% of SIGA Technologies Inc. shares and 71.1% of Arvinas Inc. shares. About 1.5% of SIGA Technologies Inc.’s share are held by insiders. Insiders Competitively, held 0.4% of Arvinas Inc. shares.


In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
SIGA Technologies Inc. 1.82% 0% 6.87% -15.28% -22.44% -29.11%
Arvinas Inc. 9.79% 16.25% 32.47% 54.04% 0% 107.63%

For the past year SIGA Technologies Inc. had bearish trend while Arvinas Inc. had bullish trend.


SIGA Technologies Inc. beats Arvinas Inc. on 7 of the 11 factors.

SIGA Technologies, Inc. engages in the development and commercialization of solutions for unmet medical needs and biothreats in the United States. Its lead product is TPOXX, an orally administered antiviral drug for treating orthopoxvirus infections. SIGA Technologies, Inc. was founded in 1995 and is headquartered in New York, New York.

Arvinas Holding Company, LLC, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110, proteolysis targeting chimeras (PROTAC) targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer; and ARV-471, a PROTAC targeting the estrogen receptor protein for the treatment of women with metastatic ER+ breast cancer. The company is also developing other PROTACs for degrading AR and other clinically relevant AR point mutations; and various other products for the treatment of neurodegenerative diseases, including tauopathies. Arvinas Holding Company, LLC was founded in 2015 and is based in New Haven, Connecticut.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.